Mr. Gabriel Makhlouf:

That would be for a variety of reasons. It is partly the fact that we have seen a recovery in the export of pharmaceuticals, which saw a dip after the pandemic. That has played a part in the growth of the economy. That is an example. Part of it is that demand remains pretty strong in the economy. There are a number of factors. Some of these, incidentally, have flipsides, which are risks.